Novavax Inc (NVAX NASDAQ) stock market data APIs
$9.8323
-0.22(-2.2%)
as of July 2, 2026
Try our APIs with
free plan!
Novavax Inc Financial Data Overview
Price chart is built with
Anychart
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Prev. Close
9.8323
Open
9.6101
High
10.0808
Low
9.5408
52 wk Range
6.2-11.97
Market Cap
1 602 M
Shares Outstanding
164 M
Revenue
596 M
EPS
-0.06
Beta
2.427
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Novavax Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Novavax Inc data using free add-ons & libraries
Get Novavax Inc Fundamental Data
Novavax Inc Fundamental data includes:
- Net Revenue: 596 M
- EBITDA: 59 532 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-06
- EPS/Forecast: -0.37
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novavax Inc News
New
WHO begins experimental Ebola trial as Congo outbreak claims 500+ lives
Patients infected with the Bundibugyo strain of Ebola have begun receiving experimental treatments in a World Health Organization-sponsored clinical trial aimed at improving care for the rare viral di...
Novavax (NVAX) Stock Moves 1.36%: What You Should Know
In the latest trading session, Novavax (NVAX) closed at $9.59, marking a +1.36% move from the previous day. Meanwhile, the Dow gained 1.14%, and the Nasdaq, a tech-heavy index, lost 0.8%. Coming into...
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry hav...
RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs
[Medication of antiviral capsule(medicine drug) for treatment and prevention of new corona virus infection(COVID-19,novel coronavirus disease 2019 or nCoV 2019 from Wuhan. Pandemic infectious concept]...
Get Novavax Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
